CS

Chintalapati Sesha Sai Nikhil

Active Director Director DIN 07076477
DIN 07076477 First appointment May 2015 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 4 active board seats
Past companies 3 historical roles
Total affiliations 7 Since May 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Chintalapati Sesha Sai Nikhil

Data last updated:

Chintalapati Sesha Sai Nikhil is a Director at Tusker Pharma India Private Limited (since 2015), Designated Partner at Azurea Fashions Llp (since 2024) and Designated Partner at Dm Fincon Services Llp (since 2024), and holds 1 more current directorship. The companies operate in Pharma and Business Outsourcing. The largest current company by reported revenue is Tusker Pharma India Private Limited at ₹40.30 Cr (FY 2019). Earlier, Chintalapati Sesha Sai Nikhil was a Designated Partner at Aceso Research Labs Llp (2021–2022) and Cfo at Astal Laboratories Limited (2023) and 1 more.

DIN 07076477
Primary Designation Director
Industry Pharma
First Appointment 12 May 2015
Oldest Company Age 11 yrs
Largest company Tusker Pharma India Private Limited Β· ₹40.30 Cr (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tusker Pharma India Private Limited U24100TG2015PTC100140
Director10 Aug 20152015₹40.30 Cr (FY 2019)Active
Designated Partner25 Sep 20242024Active
Designated Partner02 Apr 20242019Active
Designated Partner17 Jul 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 May 20212021Active
Astal Laboratories Limited L74120UP1993PLC015605
Cfo27 May 20231993₹64.36 Cr (FY 2025)Active
Schon Labs Private Limited U73100TG2013PTC089705
Director12 May 20152013₹10.05 Cr (FY 2019)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Chintalapati Sesha Sai Nikhil

NameDINCompanyDesignation
Kommera Harish03129453Tusker Pharma India Private Limited , Alsys Research LlpDirector
Mubin Khan10788717Azurea Fashions LlpDesignated Partner
Ravikanti Shailaja07629653Dm Fincon Services LlpDesignated Partner
Sudheer Karna Kankanala07591466Alsys Research LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Alsys Research Llp
Tusker Pharma India Private Limited
Azurea Fashions Llp
Dm Fincon Services Llp
Premium access

Shareholding and investment profile for Chintalapati Sesha Sai Nikhil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chintalapati Sesha Sai Nikhil

Chintalapati Sesha Sai Nikhil currently holds 4 directorships: Tusker Pharma India Private Limited (Director, since 10 Aug 2015, revenue β‚Ή40.30 Cr (FY 2019)); Azurea Fashions Llp (Designated Partner, since 25 Sep 2024); Dm Fincon Services Llp (Designated Partner, since 02 Apr 2024); Alsys Research Llp (Designated Partner, since 17 Jul 2021).

Chintalapati Sesha Sai Nikhil was first appointed on 12 May 2015 as Director at Schon Labs Private Limited. The most recent appointment on record is 25 Sep 2024 at Azurea Fashions Llp.

Chintalapati Sesha Sai Nikhil held 3 earlier board appointments: Aceso Research Labs Llp (Designated Partner, 19 May 2021 to 04 Mar 2022); Astal Laboratories Limited (Cfo, 27 May 2023 to 19 Jun 2023); Schon Labs Private Limited (Director, 12 May 2015 to 14 Feb 2019).

The current boards of Chintalapati Sesha Sai Nikhil's companies include Kommera Harish (Tusker Pharma India Private Limited), Mubin Khan (Azurea Fashions Llp), Ravikanti Shailaja (Dm Fincon Services Llp), Sudheer Karna Kankanala (Alsys Research Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available